Home / Inspections / 1269790

FDA Inspection 1269790 — Prescript Pharmaceuticals, Inc.

Prescript Pharmaceuticals, Inc. — FEI 1000135824

The FDA completed an inspection of Prescript Pharmaceuticals, Inc. on May 7, 2025 in Pleasanton, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 7, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pleasanton, CA (United States)

Facility

Other inspections at this facility

  • 1046277 (VAI Fri Mar 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 873762 (VAI Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 752730 (VAI Wed Nov 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 711361 (OAI Thu Mar 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 598180 (VAI Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources